International Journal of Stem Cells : eISSN 2005-5447

Fig. 3.

Download original image
Fig. 3. hAD-MSCs effectively improved survival and body weight. (A) Survival curve. (B) Hyperoxia exposure significantly reduced the body weight of neonatal rats. Treatment with hAD-MSCs and their derivatives did not significantly increase the body weight of neonatal rats. (C) Hyperoxia exposure significantly increased the lung weight/body weight ratio. Both the direct transfusion of cells and the transfusion of cell secretions reversed this increase. At P14: *p<0.05 vs. Normoxia group, #p<0.05 vs. Hyperoxia group.
International Journal of Stem Cells 2020;13:221-36 https://doi.org/10.15283/ijsc19110
© 2020 International Journal of Stem Cells